Published 2026-10-26
A cluster of central-bank decisions in a four-session stretch and a heavy earnings calendar converge as AI growth questions and widening high-yield credit spreads keep the near-term outlook unsettled.
Recent Events
Earnings season arrived with AI-related questions still unresolved, and Anthropic's confidential draft IPO filing added a fresh test of both growth and computing costs. Fed commentary from Powell and Warsh rounded out a light policy calendar, alongside appearances from Bowman and Waller. In credit, high-yield spreads were moving wider while defaults and buyback activity drew attention.
Macro & policy
2026-10-21Five AI quirks and conundrums to watch this earnings season
2026-10-20Exclusive / Anthropic Draft IPO Filing Shows Red-Hot Growth, Many Risks and Massive Computing Costs
2026-10-20powell: intervention_trigger
2026-10-20warsh: hawk_dove_signal
Credit & corporate
2026-10-22Credit survival: avg 48/100, 7944 in danger, Altman basis: 84% measured, 13% model-N/A, 3% data gap
2026-10-22Buybacks: 13450 active, $4467B TTM
2026-10-22HY OAS Weekly: WIDENING → hold cash
2026-10-15Buybacks: 13373 active, $4438B TTM
On the calendar
2026-10-06Bowman, Modernizing the Regulatory and Supervisory Landscape
2026-10-15Bowman, Supervisory Modernization After Silicon Valley Bank
2026-10-08Waller, The Signaling Value of the Summary of Economic Projections
Notable news
2026-10-07Medline Industries, LP
2026-10-07Draeger, Inc.
2026-10-21NVIDIA and Supply Chain Partners Expand Capacity to Accelerate AI Infrastructure Buildout - NVIDIA Newsroom
Upcoming Events
The calendar ahead is dominated by central-bank decisions that land in a tight four-session stretch, with the FOMC on October 28 followed in quick succession by the ECB, the Bank of Japan and, a week later, the Bank of England. That clustering compresses the window in which the broad market can react, and the PBOC's November 20 loan prime rate fixing sits further out as a later marker. Alongside the macro spine, the schedule carries a heavy earnings load of 235 reports over the period and a run of mid-week Treasury auctions, while a pair of drug-trial readouts and a closely watched public filing from Anthropic round out the single-name catalysts worth flagging for potential liquidity and positioning effects.
2026-10-25● phase1 readout: UBT38006 (UTHR) (US)
2026-10-26● phase3 readout: Inclisiran sodium 300 mg (NVS) (US)
2026-10-26● Anthropic Public S-1 expected (US)
2026-10-26● 26-Week BILL auction (US)
2026-10-26● 13-Week BILL auction (US)
2026-10-26● 2-Year NOTE auction (US)
2026-10-27● phase2 readout: Volrustomig (AZN) (US)
2026-10-28● FOMC monetary policy decision (US)
2026-10-29● ECB Governing Council monetary policy meeting (EZ)
2026-10-30● Bank of Japan Monetary Policy Meeting (JP)
2026-11-05● Bank of England MPC monetary policy decision (UK)
2026-11-20● PBOC Loan Prime Rate (LPR) fixing (CN)
Plus 2353 corporate earnings reports scheduled in the window.
Macro Projections
The immediate calendar hands the market three central-bank decisions in quick succession, the FOMC on 10/28, then US GDP and PCE alongside the ECB on 10/29, then the BoJ on 10/30, with all three widely expected to stand pat, so the signal will come less from the decisions themselves than from the tone around them. A hawkish set of holds would revive rate and dollar pressure, whereas soft US data would extend the global retreat in yields; either way, the private-market checks from ARES/OWL on 10/29 and APO on 11/2 add a read on the alternative-asset complex that public credit alone won't show. The backdrop is a late-cycle regime carrying inflation and term-premium pressure against resilient-growth pricing and crisis-like correlations, though not yet outright systemic credit stress. The rate shock is genuinely global: the US 30-year sits at 5.315% (94.5th percentile), the 10-year at 4.988% and the 2-year at 4.81%, while the JGB 30-year at 3.952% (99.1st), the Bund 10-year at 3.384% and the gilt 10-year at 5.334% (99.4th) all sit near their own extremes. Synchronized weekly declines at the long end, alongside narrowed US–JGB and US–Bund 10-year differentials at 2.074 and 1.604 percentage points, argue against a purely US fiscal explanation and point to a shared global force. Credit tells a more cautious story than equities: an internal CCC/BB reading has fallen from 3.51 to 1.92, but the fresher high-yield spread has widened from 3.03% on 10/6 to 3.40% on 10/22 with no tightening weeks in between, and that market signal is the one to weight tactically. The model's own disorderly-unwind probability has flattened at 36.4% across three reads after climbing from 30.6%, still below the earlier 39.8% and beneath the 41.1% attached to a slower crack, but these are model estimates rather than observations and should be treated as such. Volatility is contained but edging: the VIX at 19.03, SKEW at 151.8 and MOVE at 103.3bp all describe a market holding its shape rather than one in distress.
Near term ▬●●● expires Nov 25, 2026
The Federal Reserve will leave its target range unchanged at the 2026-10-28 FOMC and make no further policy-rate change through 2026-11-25.
Muddle-through base case, cross-validated by fed_reaction, prediction_edges and news_clips: the Fed model’s hold propensity is 77.8%, intervention propensity is stable at 26.27%, SOFR–FF is 2bp and the communication analogue is “Normal Hawkish Hold.” Reuters expects a hold; Kalshi prices a cut before 2027 at 3%, Q3 GDP above 2.5% at 81% and positive October payrolls at 88%. The 2Y Treasury at 4.81%, accelerating_pos…
Near term ▼●●● expires Nov 25, 2026
At least one daily VIX/VIX3M observation will reach or exceed 1.00, backwardation, by 2026-11-25.
VIX/VIX3M is 0.95 and accelerating_positive, VIX 19.03 is accelerating_positive after gaining 2.57 points on the week, and VVIX 109.7 is accelerating_positive; SKEW 151.8 is stable with a fat-tail bid. The central-bank/data cluster and Iran/Hormuz can force a brief stress print.
Cyclical ▼●●● expires Jan 24, 2027
During the 90 days ending 2027-01-24, HY OAS will print at least 3.60% but will not print above 4.50%: a further credit grind wider, not a disorderly break.
HY OAS widened from 3.03% on 2026-10-06 to 3.40% on 2026-10-22; the weekly signal is WIDENING/hold cash with zero tightening weeks, while rising VIX and geopolitical risk support a 3.60% touch. The cap is supported by the credit model’s MID phase, LOW false-bottom risk and accelerating_negative CCC/BB reading (3.51→1.92, as of 2026-09-30), plus Kalshi’s 4% price for a 2026 recession and 81% for Q3 GDP above 2.5%.
Cyclical ▬●●● expires Apr 24, 2027
The final available DGS30 observation in the 180-day window ending 2027-04-24 will be at least 5.00%.
UST 30Y is 5.315% at the 94.5th historical percentile, albeit decelerating_negative, and the extreme is global: JGB 30Y is 3.952% (99.1st percentile, accelerating_negative), Bund 30Y 3.618% (91.8th, accelerating_negative), and gilt 20Y 5.644% (99.2nd, accelerating_negative). Kalshi prices CPI above 3.8% at 53% and an April 2027 25bp hike at 33%.
Secular ▲●●● expires Oct 26, 2027
Over the 365 days ending 2027-10-26, MSCI EAFE total return in USD will exceed S&P 500 total return in USD.
On the same 2026-10-25 cross_region basis, developed ex-US earnings yield is 5.82% versus 4.13% for the US, a 1.69-percentage-point advantage; EM is 6.98%. US CAPE is 40.4 and implied 10-year real return 2.48% as of 2026-10-23.
Positioning
Position sizing in the model portfolio follows conviction, with each holding weighted according to a composite score that balances expected upside drift against drawdown probability, so the strongest-scoring names carry the largest weights while weaker ones stay small. That calibration sits against a credit backdrop of elevated high-yield spreads, with structural mechanisms, each carrying its historical base rate across prior firings and discounted for what the market already prices, feeding in as weighable inputs rather than forecasts. The resulting weights and the reasoning behind each holding are laid out in the model-portfolio table below.
| Name | Conviction score | Modelled drift |
|---|
| ET | 2.50 | +4.3% |
| CF | 2.25 | +1.3% |
| NTR | 2.24 | +3.5% |
| CCJ | 2.23 | -0.5% |
| LDOS | 1.44 | -4.2% |
| NXE | 1.36 | +0.3% |
op:china-ai-narrative-threat-v2 → the affected asset ▲ · 100% base rate · n=1op:hormuz-buffer-ratchet-v2 → the affected asset ▲ · 100% base rate · n=1op:trump-policy-reaction-function-v1 → the affected asset ▲ · 100% base rate · n=1
Model Portfolio
The model portfolio holds a large cash position, with money-market exposure accounting for more than four-tenths of the book as dry powder reserved for staged deployment. The deployed capital is split between an actively managed global quality equity sleeve tilted toward the AI capex cycle and a structural allocation to inflation-linked Treasuries spanning several maturities, alongside smaller positions in midstream energy infrastructure and gold.
Cash 42.0%Inflation-linked 23.8%Other 15.4%Equity 11.7%Gold & metals 7.0%
| Name | Weight | Thesis |
|---|
| Cash · 42.0% |
| Money Market | 42.0% | money-market / cash |
| Equity · 11.7% |
| QUAL | 11.7% | global quality equity |
| Inflation-linked · 23.8% |
| SCHP | 11.4% | inflation-linked Treasuries |
| VTIP | 7.0% | inflation-linked Treasuries |
| LTPZ | 5.3% | inflation-linked Treasuries |
| Other · 15.4% |
| KMI | 5.2% | passthrough |
| LDOS | 1.9% | critical materials defense |
| CCJ | 1.5% | critical materials defense |
| FCX | 1.4% | critical materials defense |
| SCCO | 1.3% | critical materials defense |
| NXE | 0.8% | critical materials defense |
| LIT | 0.7% | critical materials defense |
| COPX | 0.6% | critical materials defense |
| URA | 0.5% | critical materials defense |
| URNM | 0.3% | critical materials defense |
| NTR | 0.3% | critical materials defense |
| MP | 0.2% | critical materials defense |
| CF | 0.2% | critical materials defense |
| SQM | 0.2% | critical materials defense |
| ICL | 0.1% | critical materials defense |
| ET | 0.0% | passthrough |
| Gold & metals · 7.0% |
| IAU | 5.0% | gold / precious-metals |
| GDX | 2.0% | gold / precious-metals |
Position notes
KMI 5.2%
Full research note
Kinder Morgan is a midstream energy infrastructure company with regulated pipeline and terminal assets.
LDOS 1.9%
Full research note
Defense contractor deriving ~87% revenue from U.S. government contracts, facing budget and competition risks.
CCJ 1.5%
Full research note
No evidence provided to classify the company.
Bull case · The strongest bull case hinges on the accelerating AI data center power buildout and Cameco's strategic downstream integration. Recent catalysts include Cameco's June 2026 move to increase its stake in the tier-one Cigar Lake mine to 57.4%, alongside Westinghouse (49% owned by Cameco) securing a central role in an $80 billion U.S. government partnership to deploy AP1000 reactors. Analysts are reiterating buys on the recent dip, citing long-term uranium contract prices hitting $90/lb in Q1 2026—the highest level since 2008—which structurally insulates the company from spot market volatility.
Bear case · The bear case focuses on severe valuation overhang and near-term execution friction. Trading at over 90x trailing earnings, the stock is highly vulnerable to multiple compression if uranium spot prices stall or if AI capex digestion delays actual reactor deployments. Furthermore, recent supply chain disruptions—such as the May 2026 bridge collapse in northern Saskatchewan that temporarily halted Key Lake and McArthur River supply lines—highlight the operational fragility of remote mining assets.
Key risks• Severe valuation overhang leaving no margin of safety if uranium prices plateau or hyperscaler nuclear timelines slip.
• Operational and supply chain disruptions at key Saskatchewan mines, as evidenced by recent infrastructure washouts.
• AI data center capex digestion in the 2026–2027 window delaying the deployment of SMRs and new reactor builds.
• Geopolitical shifts that could unexpectedly reintroduce sanctioned Russian or Kazakh supply to Western markets, cooling the "security premium."
FCX 1.4%
Full research note
A copper and gold mining company exposed to commodity prices and Indonesian regulatory risks.
SCCO 1.3%
Full research note
Copper/metal miner with regulated mining concessions, exposed to commodity prices and capital intensity.
Bull case · Structural copper demand from electrification, renewable energy, and AI data centers supports long-term price appreciation; SCCO's industry-leading margins (gross margin ~59%, operating margin ~58%) and low cash costs provide a wide moat; the Tía María project and strong free cash flow generation (FCF margin ~29%) offer additional upside if copper prices remain elevated and the US-Iran peace deal temporarily eases inflation fears, potentially lowering the dollar.
Bear case · The stock trades at a significant premium to its sector (P/E 29.2 vs. peer median 26.1; P/B 12.3 vs. 2.2) with a consensus analyst target ~15% below current price and a majority of sell/underperform ratings; a potential copper demand slowdown from China's economic struggles or renewed trade war escalation, combined with a hawkish Fed holding rates high for longer, could compress multiples and trigger a sharp correction. Additionally, the recent Iran peace deal may reduce the 'safe-haven' premium that had supported commodity currencies and metals.
Key risks• Severe valuation overhang: SCCO is priced for perfection, leaving no margin of safety if copper prices retreat or costs rise.
• Geopolitical and regulatory risks in Peru, including potential mining tax overhauls and anti-mining protests that could disrupt operations.
• Macro sensitivity to a strong US dollar (the DXY remains elevated) and a potential Chinese economic slowdown, both of which would directly pressure copper prices.
• Execution risk at Tía María, a greenfield project with a history of community opposition; delays or cost overruns could erode returns.
• Elevated short interest (12.1% of float, 9.0 days to cover) signals significant bearish sentiment, increasing vulnerability to a downside catalyst-driven squeeze rather than an upside one.
NXE 0.8%
Full research note
Uranium exploration and development company focused on the Rook I project in Canada's Athabasca Basin.
NTR 0.3%
Full research note
Nutrien is the world's largest crop inputs company with a vast retail network, benefiting from scale economies.
MP 0.2%
Full research note
MP Materials operates a rare earth mine and processing facility, with commodity-linked revenue and regulatory support.
CF 0.2%
Full research note
Commodity nitrogen producer with no differentiation, exposed to price and feedstock volatility.
Bull case · The strongest bull case rests on a "tighter for longer" nitrogen market combined with sharply bullish analyst revision flow. With Middle Eastern supply offline and European natural gas prices spiking, CF's North American cost advantage is generating massive free cash flow. This dynamic has triggered a powerful R19-T10 bullish revision-momentum signal, with consensus FY2026 EPS estimates surging over 70% in the last 60 days, while the Trump administration's recent permitting boost for CF's Blue Point low-carbon ammonia project adds a durable clean-energy growth vector.
Bear case · The bear case argues that CF's recent 50%+ YTD rally has fully priced in the geopolitical premium, leaving the stock highly vulnerable to a sudden de-escalation in the Middle East. If the Strait of Hormuz reopens and Middle Eastern capacity floods back into the market, global nitrogen prices will crater, rapidly compressing CF's currently inflated margins and triggering a cyclical mean-reversion selloff.
Key risks• Geopolitical de-escalation in the Middle East rapidly normalizing global nitrogen supply.
• Cyclical mean-reversion risk following a massive 50%+ YTD rally.
• Volatility in North American natural gas prices eroding the company's structural cost advantage.
• Potential operational fatigue or unplanned outages after delaying critical maintenance at the Donaldsonville complex.
SQM 0.2%
Full research note
Lithium producer via state-owned joint venture in Chile, facing regulatory and partner risks.
ICL 0.1%
Full research note
Insufficient data to classify the company.
ET 0.0%
Full research note
Midstream energy company operating pipelines and storage with commodity and regulatory risks.
Track Record
Since the model portfolio began on 21 August 2026, it has returned -5.22% over 45 trading days against -1.00% for a daily-rebalanced 60/40 mix of SPY and AGG, a relative shortfall of 4.22%, and a hypothetical model result rather than anyone's actual account. The per-pick audit is intentionally unsparing: every evaluated idea is counted, not a favourable subset, and across 66 days of evaluated recommendations the realized hit rate ran from 38% at a one-day horizon down to 19% at four weeks, with mean alpha negative at each horizon as it lengthens; the three-month bucket has not yet begun to mature, with first outcomes due from around 20 November 2026. What the record lacks in flattery it makes up for in discipline, calls are written down before outcomes are known and scored when the horizon arrives, whatever the result. The sample is short and the longer horizons are thin, so these figures frame a starting point rather than a verdict.
-5.22%
Model portfolio return
since 2026-08-21, vs 60/40 (SPY/AGG, daily-rebalanced) -1.00%
19%
Per-pick hit rate
4w, n=98
Macro forecasts: 434 graded, 1424 open — each call is scored against what actually happened when its horizon arrived.
Positions, conflicts & disclosures
DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)
This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.
This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.
Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.
[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].
POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.
CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.
MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.
Intended transactions: the affiliated automated system has open or queued target allocations in the following securities discussed here: LTPZ, QUAL, SCHP, VTIP. These are real pending orders or model target weights in accounts belonging to the publication's operator, disclosed for transparency under our Trading & Publication Policy [link] — not a recommendation, and our interests may differ from yours.
Positions held: the publisher and/or operator currently holds positions in the following securities discussed here: CCJ, CF, COPX, ET, FCX, GDX, IAU, ICL, KMI, LDOS, LIT, MP, NTR, NXE, SCCO, SQM, URA, URNM.
